Mr. Han is mainly engaged in the research and development of blood vascular cell and molecular biology and biotechnology. He has made many international leading academic achievements in stem cell, megakaryocyte and platelet.
Leading the completion of a number of projects in the industry of investment and financing. He has been involved in the capital operation of a number of companies in the GF Securities Investment Banking Department.
He has served in Ping An (Group) Innovation Investment Fund, China International Capital Corporation and other institutions, with a wealth of domestic and foreign medical industry investment experience.